Table 1.
Psoriasis associated DMSs | SNPs associated with DMSs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Illumina ID* | Gene_context | Gene name | P value (Meth vs. Pheno) | Beta difference | SNP | Map | Nearby gene | P value (Geno vs. Pheno) | Adjusted P value (Meth vs. Geno) | Adjusted independent P value (Geno vs. Pheno) | CIT P† |
cg04087571 | Body | SIK3 | 1.69E−10 | −0.11 | rs13203895 | 31276305 | USP8P1 | 4.80E−08 | 0.022 | 0.004 | 0.022 |
cg04087571 | Body | SIK3 | 1.69E−10 | −0.11 | rs2853953 | 31267728 | HLA-C | 2.77E−08 | 0.024 | 0.010 | 0.024 |
cg04087571 | Body | SIK3 | 1.69E−10 | −0.11 | rs10484554 | 31306778 | WASF5P | 2.54E−08 | 0.027 | 0.005 | 0.027 |
cg04087571 | Body | SIK3 | 1.69E−10 | −0.11 | rs2245822 | 31263023 | HLA-C | 1.83E−08 | 0.027 | 0.010 | 0.027 |
cg04087571 | Body | SIK3 | 1.69E−10 | −0.11 | rs2853952 | 31268092 | HLA-C | 2.54E−08 | 0.027 | 0.008 | 0.027 |
cg09914444 | TSS1500 | DMBX1 | 1.47E−10 | −0.11 | rs13203895 | 31276305 | USP8P1 | 4.80E−08 | 0.034 | 0.027 | 0.034 |
cg09914444 | TSS1500 | DMBX1 | 1.47E−10 | −0.11 | rs2245822 | 31263023 | HLA-C | 1.83E−08 | 0.037 | 0.037 | 0.037 |
cg09914444 | TSS1500 | DMBX1 | 1.47E−10 | −0.11 | rs10484554 | 31306778 | WASF5P | 2.54E−08 | 0.042 | 0.030 | 0.042 |
cg06834507 | Body | C1orf106 | 5.00E−12 | −0.11 | rs13203895 | 31276305 | USP8P1 | 4.80E−08 | 0.046 | 0.005 | 0.046 |
cg06834507 | Body | C1orf106 | 5.00E−12 | −0.11 | rs2853953 | 31267728 | HLA-C | 2.77E−08 | 0.047 | 0.007 | 0.047 |
cg09914444 | TSS1500 | DMBX1 | 1.47E−10 | −0.11 | rs2853953 | 31267728 | HLA-C | 2.77E−08 | 0.041 | 0.047 | 0.047 |
Gene name: According to HUGO Gene Nomenclature Committee; Gene_context: Location of the gene associated CpG-site(s) with respect to the gene context
*Illumina ID is arranged by significance rank of CIT test
†CIT P: the maximum of the component P-values for an omnibus test